Patent Disputes Hit Manufacturers the Hardest

As fear over the spread of coronavirus intensifies, researchers around the globe are scrambling to find a cure. The antiviral drug remdesivir is showing promise, both in the United States and China. Yet as seen all too often, patent disputes have emerged between U.S. pharmaceutical company Gilead and Chinese researchers working on a cure. Disputes like this often grab headlines, as do patent wars between tech giants like Apple and Qualcomm. But most conflicts over patents fail to garner this kind of attention. In fact, most people who find themselves entangled in a patent struggle lack the resources of large pharmaceutical and tech companies, leaving them vulnerable to patent litigation that can end in bankruptcy

Read More: Real Clear Health